Individualised Dose Optimisation of Ganciclovir in Immunocompromised Children Trial (ID-MAGIC)

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(7 sites)

Australia

Sydney Children's Hospital, Sydney, New South Wales

The Children's Hospital at Westmead, Sydney, New South Wales

Queensland Children's Hospital, Brisbane, Queensland

The Royal Children's Hospital, Melbourne, Victoria

Monash Children's Hospital, Melbourne, Victoria

Perth Children's Hospital, Perth, Western Australia

New Zealand

Starship Children's Hospital, Auckland, North Island